Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse

doi:10.3748/wjg.v22.i21.5079

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8175)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

678

WORD

282

HTML

3926

Figures (1-6)

383

Tables (1-2)

272

Sum=5541

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

875

Download

1759

Sum=2634

Jun 7, 2016 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jun 7, 2016; 22(21): 5079-5087
Published online Jun 7, 2016. doi: 10.3748/wjg.v22.i21.5079

Table 1 Incidence of clinical characteristics among participants

Total	194
Gender, n (%)
Male	99 (51)
Female	95 (49)
Extent of disease, n (%)
Pancolitis	125 (64)
Left-side colitis	48 (25)
Proctitis	21 (11)
Median (IQR) age at onset	32 (22-43)
Median (IQR) duration of disease, months	107 (51-194)
Median (IQR) age of undergoing colonoscopy	44 (33-56)
Median (IQR) duration of sustaining clinical remission at the time of colonoscopy, months	11 (6-23)
Concomitant medications, n (%)
Aminosalicylate	178 (92)
Corticosteroids	27 (14)
Mercaptopurine/Azathioprine	79 (41)
Tacrolimus	10 (5)
Biologics	9 (5)
Colonoscopy findings, n (%) (maximum index in the colorectum)
MES 0	94 (49)
MES 1	57 (29)
MES 2	39 (20)
MES 3	4 (2)
Fecal Hb concentrations (ng/mL), n (%)
0-100	111 (57)
101-1000	56 (29)
1001-10000	20 (10)
10001-	7 (4)

MES: Mayo Endoscopic subscore; Hb: Hemoglobin; IQR: Interquartile range.

Citation: Nakarai A, Kato J, Hiraoka S, Takashima S, Takei D, Inokuchi T, Sugihara Y, Takahara M, Harada K, Okada H. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse. World J Gastroenterol 2016; 22(21): 5079-5087
URL: https://www.wjgnet.com/1007-9327/full/v22/i21/5079.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i21.5079